Open AccessDe novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination1
Author(s) -
Róbert Langer,
Charles T. Van Buren,
Stephen M. Katz,
Barry D. Kahan
Publication year - 2002
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200203150-00017
Subject(s) - medicine , gastroenterology , sirolimus , immunosuppression , renal function , creatinine , hemodialysis , transplantation , discontinuation , kidney transplantation , ciclosporin , kidney disease , urology
We sought to examine factors that predisposed 1.5% (10/672) of renal transplant recipients treated with a cyclosporine (CsA)/sirolimus (SRL)/steroid immunosuppressive regimen to develop hemolytic uremic syndrome (HUS).